Inj, hydromorphone, 0.1 mg
Products billed under this code include Dilaudid, Hydromorphone HCl.
Payment limit per 0.1 MG, by effective quarter, 4Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J1171
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Dilaudid | FreseniUS Kabi USA, LLC | 76045-0009-06 | 50 | $11.20 |
| Dilaudid | FreseniUS Kabi USA, LLC | 76045-0009-11 | 100 | $22.40 |
| Dilaudid | FreseniUS Kabi USA, LLC | 76045-0010-11 | 200 | $44.80 |
| Hydromorphone HCl | Pfizer Inc | 00409-1283-31 | 100 | $22.40 |
| Hydromorphone HCl | Pfizer Inc | 00409-1283-37 | 100 | $22.40 |
| Hydromorphone HCl | Pfizer Inc | 00409-1304-31 | 400 | $89.60 |
| Hydromorphone HCl | Pfizer Inc | 00409-1312-30 | 200 | $44.80 |
| Hydromorphone HCl | Pfizer Inc | 00409-1312-36 | 200 | $44.80 |
| Hydromorphone HCl | Pfizer Inc | 00409-1805-01 | 25 | $5.60 |
| Hydromorphone HCl | Pfizer Inc | 00409-2634-01 | 1000 | $224.00 |
Show all 29 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Hydromorphone HCl | Pfizer Inc | 00409-2634-05 | 5000 | $1,120.00 |
| Hydromorphone HCl | Pfizer Inc | 00409-2634-50 | 5000 | $1,120.00 |
| Hydromorphone HCl | Pfizer Inc | 00409-3365-10 | 200 | $44.80 |
| Hydromorphone HCl | Pfizer Inc | 00409-4264-01 | 50 | $11.20 |
| Hydromorphone HCl | Hikma Pharmaceuticals USA Inc. | 00641-2341-41 | 400 | $89.60 |
| Hydromorphone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6151-25 | 500 | $112.00 |
| Hydromorphone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6169-10 | 100 | $22.40 |
| Hydromorphone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6206-10 | 50 | $11.20 |
| Hydromorphone HCl | Hikma Pharmaceuticals USA Inc. | 00641-6259-10 | 20 | $4.48 |
| Hydromorphone HCl | Teva Parenteral Medicines, Inc. | 00703-0018-01 | 5000 | $1,120.00 |
| Hydromorphone HCl | Teva Parenteral Medicines, Inc. | 00703-0110-03 | 1000 | $224.00 |
| Hydromorphone HCl | Teva Parenteral Medicines, Inc. | 00703-0113-03 | 5000 | $1,120.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 63323-0851-10 | 1000 | $224.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 63323-0851-15 | 5000 | $1,120.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 63323-0851-50 | 5000 | $1,120.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 63323-0852-25 | 250 | $56.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 63323-0853-25 | 500 | $112.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 63323-0854-10 | 1000 | $224.00 |
| Hydromorphone HCl | FreseniUS Kabi USA, LLC | 76045-0121-11 | 20 | $4.48 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.224 | +$0.088 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.136 | +$0.035 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.101 | −$0.039 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.14 | +$0.045 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.095 | +$0.01 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted September 8, 2026 |
| 3Q25 | $0.085 | −$0.052 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted March 10, 2026 |
| 2Q25 | $0.137 | +$0.048 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted March 10, 2026 |
| 1Q25 | $0.089 | +$0.004 | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted December 19, 2025 |
| 4Q24 | $0.085 | – | 0.1 MG | Inj, hydromorphone, 0.1 mg | v1, posted June 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025